Bicycle Therapeutics names new CFO, shares fall
** Shares of drug developer Bicycle Therapeutics Plc
BCYC.O down 5.9% at $25.34
** Co appoints Alethia Young as its chief financial officer
to replace Lee Kalowski, effective 17 July
** Prior to joining Bicycle, Young served as CFO at Graphite
Bio GRPH.O
** BCYC also promotes SVP Finance Travis Thompson to SVP,
chief accounting officer
** BCYC shares down 12.33% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics Q1 revenue drops after partnership terminations
Brief: Bicycle Therapeutics Announces Oral And Poster Presentations At The Aacr Annual Meeting 2026
UK's Bicycle Therapeutics Q4 revenue jumps, proposes 30% workforce reduction
Brief: Bicycle Therapeutics Says Travis Thompson Appointed As CFO, Succeeds Alethia Young
Bicycle Therapeutics Q3 net loss widens as R&D costs rise